All data are based on the daily closing price as of April 28, 2025
s

Sunmax Biotechnology

4728.TWO
13.92 USD
0.14
+1.02%

Overview

Last close
13.92 usd
Market cap
758.29M usd
52 week high
13.92 usd
52 week low
6.05 usd
Target price
N/A usd

Valuation

P/E
35.9839
Forward P/E
N/A
Price/Sales
13.6156
Price/Book Value
16.1282
Enterprise Value
743.27M usd
EV/Revenue
25.4184
EV/EBITDA
26.4781

Key financials

Revenue TTM
56.01M usd
Gross Profit TTM
45.55M usd
EBITDA TTM
30.64M usd
Earnings per Share
0.38 usd
Dividend
0.36 usd
Total assets
56.44M usd
Net debt
N/A usd

About

Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax FACIALGAIN collagen implant with lidocaine, Sunmax collagen implant I-Plus, Sumax collagen implant I, Sunmax FACIALGAIN collagen implant 1-Plus with lidocaine for the correction of facial defects, such as the fill up of wrinkles; and Porcogen, a sterile purified collagen solution for medical device, tissue engineering, and research purposes. It also provides Sunmax collagen dental bone graft, Sunmax collagen dental membrane, and Sunmax dental bone graft granules, which are used in the augmentation or reconstructive treatment of the alveolar ridge. In addition, the company offers Sunmax collagen bone graft matrix that provides a bone void filler that is resorbed and replaced with bone during the healing process; and skincare products comprising Sunmax 12 jiao didi spray, Sunmax 11 collagen moisturizing cream, and Sunmax collagen skincare that are used as aftercare of dermal filler treatment. Sunmax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Tainan City, Taiwan.
  • Symbol
    4728.TWO
  • Exchange
    TWO
  • Isin
    TW0004728001
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
  • Headquarter
    Tainan City
  • Web site
    https://www.sunmaxbiotech.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top